MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Omega Diagnostics upscaling production amid report of Covid contract win

StockMarketWire.com

Disease test kit supplier Omega Diagnostics confirmed it was upscaling its manufacturing capabilities, while acknowledging a media report stating that it had been selected by the UK government to produce Covid-19 rapid tests.

Omega Diagnostics said it had noted a report in the Financial Times, which said it was among three companies selected to produce up to 2 million lateral flow devices per day for the UK.

'The company can confirm that it is continuing to modify its Alva-based facility to upscale significantly its lateral flow test production capacity,' Omega Diagnostics said.

'When contracts or supply agreements are signed to utilise this capacity the company will announce this in line with AIM disclosure obligations.'



Story provided by StockMarketWire.com